EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Autoimmunity


 

Status
active
Indexing
Cambridge Scientific Abstracts; Current Awareness in Biological Sciences (CABS); Current Contents; Excerpta Medica; Index Medicus/MEDLINE; PubMed; PASCAL; Reference Update, Scopus, Science Citation Index and SIIC.
Subject

Source type
Journal
Publisher
ISBN ISSN
0891-6934
E ISSN
1607-842X
First volume
1
Last volume
41
Homepage
Description

Current understanding of autoimmune disease is being increasingly underpinned by the new molecular sciences. Progress in this area has been little short of spectacular, and all clinical specialities now recognise autoimmunity as a major component of the diseases with which they are involved.

Autoimmunity is an international, peer reviewed journal that publishes articles of clinical and basic science on the pathogenesis, immunology, genetics, molecular biology, and treatment of autoimmune diseases. In addition to the basic mechanisms and elements of the immune system, the journal focuses on the autoimmune processes associated with systemic lupus erythematosus, rheumatoid arthritis, Sjogren syndrome, diabetes, multiple sclerosis, and other systemic and organ-specific autoimmune diseases. The journal is not restricted to any disease type or clinical speciality, but reflects the areas where scientific progress is most rapid and clinical applications significant and widespread.

The journal is valuable to clinicians and researchers in immunology and molecular biology.












Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )